Good vaccine news and a flurry of stock sales by executives. There’s a pattern, study finds

As they raced to develop vaccines against COVID-19, executives at some pharmaceutical companies collected huge windfalls by selling stock around the time their companies announced positive news about the vaccines. READ MORE